via acetylated low-density lipoprotein uptake and Ulex europaeus lectin binding, (iii) tube-like network formation in Matrigel, (iv) endothelial-specific surface antigen expression, (v) self-renewal potential displayed by the most proliferative cells and (vi) assessment of their ability to form new blood vessels in an in vivo mouse implant model 13 .
Comparison with existing methods
Recently, three papers have demonstrated the existence of endothelial progenitor-like cells with a high potential for proliferation in the peripheral microvasculature of rat 19, 20 and mouse 21 lungs. The Stevens group isolated ECFC-like cells from peripheral rat lung tissue after collagenase digestion, plating and selection of late-outgrowth endothelial colonies 19 . The cells were cultured in DMEM supplemented with 10% (vol/vol) FBS and antibiotics, and they were observed to demonstrate ECFC-like phenotype, on the basis of both expression of surface antigens and functional behaviors such as uptake of low-density lipoprotein (LDL), maintenance of high barrier resistance, and in vitro and in vivo vasculogenesis in Matrigel 20 . Weich and colleagues 21, 22 , in contrast, selected out CD31 + cells from mouse peripheral lung microvasculature by successively using MACS and fluorescenceactivated cell sorting (FACS). They expanded these cells in DMEM enriched with 20% (vol/vol) FBS and demonstrated their expression of panendothelial cell surface markers 22 and the ability to bind Griffonia simplicifolia lectin. These cells were also negative for CD45, CD117 (c-kit or stem cell factor (SCF) receptor) and CD41, which are markers for leukocytes and hematopoietic stem and progenitor cells. By using limiting dilution assays at singlecell seeding density, they show that at least 15% of those cells were capable of a very high proliferation rate. These cells also generated blood vessels of donor origin in Matrigel plugs implanted subcutaneously (s.c.) in recipient mice.
In a recent study, we combined CD31 + selection and clonal ring isolation of endothelial colonies and expanded the derived cells to establish primary endothelial cell lines from rat and human peripheral lung vasculature 17 . These cells were assessed for surface marker expression and a panel of functional assays that defined them as ECFCs 13, 18 . In this article, in addition to providing a detailed step-by-step description of this technique, we also provide a troubleshooting guide for the routine issues that might arise during the isolation process. The focus of this protocol is on resident lung ECFCs, and we have not compared lung and other organ ECFCs. Rafii et al. 23 used lectin staining to isolate human bone marrow microvascular cells and showed that they displayed the same antigens as human umbilical vein endothelial cells (CD31, CD34, von Willebrand factor and uptake of AcLDL).
Applications of the method
We have tested this protocol in adult human and rat lung samples 17 . It also allows the isolation of ECFCs from developing rat and human lungs-i.e., lungs from newborn rats as early as 14 d of age or from aborted human fetuses at 18-20 weeks of gestation 17 . Isolation and culture of lung-resident ECFCs from these samples allows functional assessment of these cells in experimental and clinical lung diseases. ECFCs isolated and expanded by this technique can also be used in therapeutic studies. In addition, the described protocol enables the isolation and culture of a properly defined subset of endothelial cells with demonstrable progenitor-like characteristics (i.e., a population of 'lineage-specific' endothelial progenitor cells); this will enable an improved understanding of endothelial cell biology.
Limitations
The sensitivity of the current protocol to successfully isolate lung ECFCs is limited by the vascular density of the starting tissue that is being processed. The existing method probably requires capturing a threshold number of CD31 + cells for successful expansion and establishment of pure ECFC cultures. This was evident from our inability to successfully isolate and establish ECFC cultures
Step 
and 0.8 U dipase per mg of lyophilizate) per milliliter of double-distilled (dd) water. Store this solution at −20 °C for up to one month. On the day of the experiment, dilute the 5× stock five times with Dulbecco's PBS.  crItIcal Prepare the working dilution on the day of the experiment. Collagen type I solution Dilute 0.575 ml of glacial acetic acid (17.4 N) in 495 ml of dd water (final concentration, 0.02 N) and filter-sterilize it with a 0.22-µm vacuum filtration system. Dilute collagen type I stock with 0.02 N acetic acid to yield a 50 µg/ml working dilution. The volume of collagen to use will vary depending on the supplied collagen stock concentration. Store this solution for up to 1 week at 4 °C.
Sterile vacuum grease Spread a small amount of vacuum grease into a thin layer in an autoclavable glass dish. After setting the lid, wrap the glass dish in aluminum foil, autoclave it and cool it completely. This can be prepared and stored in sterile conditions at room temperature (18-25 °C) for up to 6 months.. Coating of cell culture surfaces with collagen type I Add the working dilution (50 µg/ml) of collagen type I solution to the surface to be coated. Use 1 ml for each well of a six-well plate, 300 µl per well for 24-well plates, 2-3 ml for a 25-cm 2 flask and 5-6 ml for a 75-cm 2 flask. Incubate the plates and flasks 90 min to overnight at 37 °C.  crItIcal The flasks and plates must be used within 24 h of coating.
proceDure preparation of reagents  crItIcal Work in strictly aseptic conditions (preferably under the cell culture hood) at all times. 1| Prepare two or three 15-or 50-ml centrifuge tubes with fresh DMEM + 1% (vol/vol) antibiotic/antifungal solution and place it over ice (4 °C); the tubes are then ready to use.
2|
Preheat the incubator to 37 °C.
preparation of anti-cD31-tagged magnetic beads 3| Take 1 mg (100 µl of supplied suspension) of streptavidin-tagged M-280 Dynabeads in a 1.8-ml cryovial.
4|
Add 500 µl of MACS buffer and mix it well.
5| Place the cryovial in the magnet for 1 min, and pipette off the supernatant completely.
6|
Remove the cryovial from the magnet and resuspend the washed Dynabeads with 500 µl of MACS buffer.
7|
Repeat Steps 5 and 6 two more times.
8|
At the end of the third wash, resuspend the Dynabeads in MACS buffer and add 10 µg of biotinylated anti-CD31 antibody while mixing, to obtain an overall volume of 100 µl.  crItIcal step The volume of the antibody solution containing 10 µg of antibody varies depending on the supplied concentration. Add an appropriate volume of antibody solution first and then make it up to 100 µl by adding MACS buffer.
9|
Incubate the mixture for 30 min at room temperature with gentle tilting and rotation.
10| Add 500 µl of MACS buffer and pipette it up and down several times.
11|
Wash the Dynabeads three times, as described in Steps 5 and 6.
12|
Resuspend the Dynabeads in 100 µl of MACS buffer. Leave it on ice (4 °C) until use.  pause poInt Anti-CD31-tagged magnetic beads can be prepared as described above, 1 d before the experiment, and they can be stored at 4 °C until use. This reduces the effort on the day of the experiment, especially if you are performing this protocol for the first time.
preparation of lung samples 13| To isolate human cells, follow option A. To isolate rat cells, follow option B.
(a) Human cells (i) Collect fetal or adult biopsied or autopsied lung samples into 15-or 50-ml centrifuge tubes with basal-DMEM (prepared in Step 1) and immediately store them on ice.  pause poInt Biopsies can be stored on ice for up to 24 h. The lung samples should ideally be processed for ECFC isolation, on the same day. In some circumstances, immediate processing may not be possible, if, for example, lungs are shipped from another center. In this case, carefully store the lungs at 4 °C in basal-DMEM for not more than 24 h. In the authors' experience, ECFC colonies can be isolated after this holding period; however, the number of colonies will decrease as the time between sample collection and processing increases. Samples should not be allowed to freeze at any time during shipment.
(B) rat cells (i) Euthanize the rat using sodium phenobarbitol (65 mg/kg, injected intraperitoneally (i.p.)).
(ii) Wet the chest of the rat with 70% (vol/vol) ethanol, and open the chest of the rat with anatomical scissors.
(iii) Remove whole lungs of the rat with anatomical scissors and tweezers.
(iv) Transfer the lungs into 15-or 50-ml centrifuge tubes with basal-DMEM (prepared in Step 1), and immediately store them on ice.
Isolation of total lung cells 14|
Transfer the lungs from the centrifuge tubes into a Petri dish.
15| Wash whole lungs with serum-free basal-DMEM.
16|
If you are using rat tissue, slice the peripheries of lung lobes, by discarding the contents of the hilum and the proximal alveolar tissue. Remove thin strips of alveolar tissue subjacent to the pleural surface. Alternatively, for the human lung, trace the pleural surface of the supplied lung piece and remove strips of tissue immediately underlying the pleural surface.
17| Add a few drops of basal-DMEM and chop the lung tissue using sterile, disposable blades to very small pieces (~1-2 mm 2 ) that could be drawn into a 5-ml pipette.
18|
Transfer the pieces into a 15-ml centrifuge tube containing 1× working dilution of collagenase/dispase digestive solution (7-10 ml per 0.5 g of wet tissue).
19|
Digest the lung at 37 °C for 45 min under continuous horizontal shaking (300 r.p.m.).
20|
Quench the lung-digestive solution mixture with an equal volume of complete-DMEM.
21|
Draw the mixture up and down several times using a 5-ml pipette.
22| Place a 70-µm cell strainer on a 50-ml tube.
23|
Under sterile conditions, strain the lung digest through the 70-mm cell strainers by releasing the lung digest on the cell strainer using a 5-ml pipette. ! cautIon Slowly release the lung digest on the strainer to avoid overflowing of the digested suspension. More than one 70-mm cell strainer may be needed at this step.
24|
Wash the cell strainer with 2-3 ml of complete-DMEM.
25|
Re-strain the cell suspension through a 40-µm cell strainer into a 50-ml centrifuge tube.
26|
Centrifuge the 50-ml tube at 300g at 4 °C for 10 min.
27|
Decant the supernatant and resuspend the cell pellet in 10 ml of complete-DMEM.
28|
Centrifuge the 50-ml tube at 300g at 4 °C for 10 min. 31| Centrifuge the unstained cell suspension at 300g for 10 min at 4 °C.
32|
Decant the supernatant and resuspend the cell pellet in 1 ml of MACS buffer per 10 7 total cells. Strain the cell suspension through a 40-µm cell strainer to remove any cell aggregates. 
34|
Incubate the cells for 30 min at 2-8 °C with gentle tilting and rotation.  crItIcal step Use a mixer that provides tilting and rotation of the tubes to ensure that the Dynabeads do not settle at the bottom of the tube. Strictly adhere to the incubation time and temperature to reduce phagocytic activity and other metabolic processes and to avoid lower purity or viability of the isolated cells.
35| Double the cell suspension volume with MACS buffer to limit the trapping of unbound cells.
36|
Place the tube in a magnet in aseptic conditions for 2 min.
37|
Discard the supernatant and gently wash the bead-bound cells with 1 ml of MACS buffer.
38|
Place the tube in the magnet for 1 min and discard the supernatant.
39|
Repeat Steps 37 and 38 four times. At the end, add enough MACS buffer to thoroughly resuspend all cells that would have adhered to the walls of the tube. Centrifuge the cell suspension at 300g for 10 min at 4 °C. Aspirate the supernatant.
40|
Resuspend the cells in cEGM-2 to obtain a suspension of 7.5 × 10 4 to 1.0 × 10 5 cells per ml.
? trouBlesHootInG plating of cD31 + cells in culture 41| Remove the rat-tail collagen type I solution from a collagen-coated six-well tissue culture plate and wash the surface twice with PBS (using 2 ml of PBS per well).  crItIcal step This step must be done immediately before plating the well plate with cells.
42| Pipette 2 ml (~4,000-5,000 cells) into each well of the six-well plate precoated with rat-tail collagen type I and place it in a 37 °C, 5% CO 2 humidified incubator.
43|
After 24 h (day 1), slowly remove the medium from the well with a pipette.  crItIcal step Aspirate the medium slowly at a rate of 1 ml per 4-5 s. A small quantity of medium should be left behind in the well to prevent drying of the plate surface.
44|
Slowly add 2 ml of cEGM-2 to the well. Return the plate to the incubator.
45|
Refresh the medium daily (as described in Steps 43 and 44) until day 7 and every other day thereafter. ECFC colonies should appear between days 4 and 14 of culture as well-circumscribed areas of cobblestone-appearing cells (Figs. 3 and 4a , white arrows). Individual colonies should be isolated and expanded as described in the following steps between days 7 and 14. Mesenchymal stem cell (MSC)-like contaminating cells appear as dendritic or fibroblast-like cells (Figs. 3 and 4a , white arrowhead; Fig. 4b,c) that can overgrow ECFCs.  crItIcal step To ensure a pure subculture of ECFCs, ECFC colony isolation should be done very soon after contaminating cells are seen.
ecFc colony isolation 46| Visualize the ECFC colonies using an inverted microscope, and outline the colony boundaries with a fine-tipped marker on the underside of the well. 47| Use sterile forceps to pick a cloning cylinder from its packing, and dip the bottom surface into autoclaved vacuum grease to acquire a uniform coating.  crItIcal step Always apply the minimum amount of vacuum grease necessary to uniformly coat the bottom surface of the cloning cylinder and form a good seal with the culture plate. Too much grease will interfere with cell collection. Prepare cloning cylinders just before use.
48|
Aspirate the culture medium and wash the well with 2-3 ml of PBS.
49|
After aspirating the PBS, set a clonal ring around each colony and press it firmly against the plate with forceps. ! cautIon Carefully apply vertical pressure to seal the cloning cylinder against the culture plate. Avoid any inadvertent sliding of the cylinder, as this can disrupt the ECFC colony.
50| Use a 20-200-µl pipette to add 50-150 µl of warm trypsin-EDTA into each cloning cylinder.  crItIcal step Make sure that sufficient quantity of trypsin-EDTA is added to cover the entire area within the cloning cylinder. 53| When all cells within the cloning cylinder have detached, place the tip of the pipette into the center of the cylinder and pipette up and down several times.
54|
Collect the entire volume into a sterile microcentrifuge tube containing an equal volume of cEGM-2 and mix well.
55|
Wash the area within the cloning cylinder one or two times with 200 µl of cEGM-2, and then transfer the washes into the sterile microcentrifuge tube until all detached cells are collected into the microcentrifuge tube.
56|
Remove the rat-tail collagen type I solution from a collagen-coated 24-well tissue culture plate, and then wash the surface twice with PBS (using 1 ml of PBS per well).  crItIcal step This step must be done immediately before plating the well plate with cells.
57|
Seed the cells from each ECFC colony into one well of the 24-well cell culture plate precoated with rat-tail type-I collagen in a total volume of 1 ml of cEGM-2, and culture them in a 37 °C, 5% CO 2 humidified incubator for expansion.  crItIcal step If the ECFC colony is small (fewer than 100 cells), cells from two or three colonies can be pooled and plated into one well of a 24-well cell culture plate. ? trouBlesHootInG Further purification and expansion of ecFcs 58| When cells in the 24-well plate approach confluence, remove the cell culture medium and wash the culture surface with PBS.
59|
After removal of PBS, add 100 µl of trypsin-EDTA per well of the 24-well plate and incubate the plates for up to 5 min until the cells have completely detached.
60|
Pipette up and down thoroughly with 500 µl of cEGM-2 to collect the detached cells into a 15-ml centrifuge tube.
61| Wash the well one or two times with 500 µl of cEGM-2 until all detached cells are collected into the centrifuge tube.  crItIcal step Cells from up to two or three confluent wells can be pooled into one centrifuge tube.
62|
Make the volume of the cell suspension up to 12-14 ml with cEGM-2, and mix it well by pipetting up and down gently.
63|
Remove the rat-tail collagen type I solution from a collagen-coated 75-cm 2 vented tissue culture flask, and wash the surface twice with PBS (using 10 ml of PBS per well).  crItIcal step This step must be done immediately before plating the well plate with cells.
64|
Plate the cells in the 75-cm 2 vented tissue culture flask precoated with rat-tail type-I collagen and culture in a 37 °C, 5% CO 2 humidified incubator for expansion.
65|
Replace the culture medium with fresh cEGM-2 every other day and culture until cells approach 80-90% confluence.  crItIcal step Cultures should reach 80-90% confluence in 4-7 d. ? trouBlesHootInG 66| When the tissue culture flasks have approached 80-90% confluence, carefully examine the cultured cells using an inverted microscope to spot areas of MSC-like contaminating cell colonies as opposed to the uniform cobblestone-appearing ECFC monolayer.  crItIcal step It is not uncommon to find MSC-like contaminating cell colonies interspersed with the ECFCs in early passages of the culture. The contaminating cells appear as described in
Step 45. The ECFCs can be purified further by performing ~3-5 cycles of CD31 + magnetic selection and subculturing, as described in Steps 67-75.
67|
Remove the culture medium from the cell culture flasks and wash the culture surface liberally with PBS.  crItIcal step For a 75-cm 2 tissue culture flask, use 8-10 ml of PBS for the washes.
68| Aspirate PBS and add 3 ml of trypsin-EDTA per 75-cm 2 culture flask.  crItIcal step Warm the trypsin-EDTA to 37 °C before use.
69|
Incubate the flask at 37 °C until the cells detach completely.
? trouBlesHootInG 70| Add 8-10 ml of cEGM-2, and collect the cells completely into a 15-ml centrifuge tube.
71|
Centrifuge the 15-ml tube at 300g at 4 °C for 5 min.
72|
Decant the supernatant and resuspend the cell pellet in 1 ml of MACS buffer.
73|
Take up 10 µl of the ECFC suspension and mix it with 10 µl of trypan blue.
74|
Apply 10 µl of this mixture into a modified Neubauer chamber and count the cells.  crItIcal step Usually, a confluent 75-cm 2 tissue culture flask contains 2-4 million ECFCs. Up to 10 7 cells can be suspended in 1 ml of MACS buffer.
75|
Perform a MACS selection of CD31 + cells according to the procedure described in Steps 31-40.  crItIcal step This step is to remove the MSC-like contaminating cells (Fig. 4) and to obtain a pure culture of ECFCs. If the contaminating cells are still present upon further passage, repeat MACS selection of CD31 + cells at each passage until a pure ECFC culture is obtained. FACS-based selection for CD31 + cells may also be considered at this step. Usually, pure ECFC cultures are obtained after 2-4 cycles of CD31 + selection performed over 2-4 passages.
? trouBlesHootInG Troubleshooting advice can be found in table 1. For rat lung, it is best to process it immediately after excision. For human lung, if immediate processing is not feasible or if it is being shipped from another center, carefully store it at 4 °C in basal-DMEM for not more than 24 h. Samples should never be allowed to freeze anywhere during this storage period
Too long or too vigorous shaking during enzymatic digestion step Do not leave the chopped lung sample for more than 45 min in prewarmed collagenase/dispase. Do not shake at speeds greater than 300 r.p.m. Insufficient enzyme digestion Make sure that the tissue is chopped adequately (to obtain 1-2 mm 3 pieces). Also make sure that there is sufficient enzyme added to the chopped tissue (~10 ml of enzyme solution (working dilution) per 0.5 g of tissue)
Insufficient washing of cells (with beads attached)
In Steps 37 and 38, make sure that the cells (with attached beads) are washed sufficiently and properly suspended in MACS buffer to minimize CD31 + cell loss Too many contaminating cells around ECFC colonies (Fig. 4) Antibody problem Antibodies may not be very specific. Use antibodies from standard manufacturers, preferably the same ones used in this protocol. Do not subject antibodies to repeated freeze-thaw cycles and leave them on ice all the time before use
Ineffective coating of cells with anti-CD31-tagged Dynabeads Strictly adhere to the incubation time and temperature specified in the protocol. High phagocytic activity will result in non-CD31 + cells being selected out in large numbers antIcIpateD results
Initiation and propagation of ecFcs
ECFC colonies appear between 7 and 14 d of culture. Routinely, embryonic human lung samples can be expanded to 10 7 cells in 5-6 weeks. Rat lungs, in contrast, may require a longer time (6-8 weeks) to yield the same number of ECFCs. Both rat and human lung vascular ECFCs have the potential to be cultured for up to 15 passages before they start expressing morphological indications of senescence such as slow multiplication and appearance of cytoplasmic vacuoles. These observations are consistent with previous studies on human adult EPCs 15, 18 .
phenotypic characterization of lung vascular ecFcs
Lung vascular ECFCs grow as a monolayer with the characteristic 'cobblestone' morphology. They ingest AcLDL, bind Ulex europaeus lectin and form capillary tube-like networks when they are plated on Matrigel ( Fig. 5a ; see also supplementary table 1 for information about antibodies used in this figure) . ECFCs uniformly express typical endothelial cell surface antigens CD31, CD146,
Endothelial network formation
Ulex Dil-AcLDL Hoechst , and endoglin (CD105), and they were negative for hematopoietic cell-specific CD45 and monocyte/macrophage-specific CD14. Filled gray histograms represent antigen staining with negative isotype controls overlaid in white. (c) Human lung ECFCs were capable of giving rise to clusters (2-50 cells) or colonies (51-500 cells or 501 or more cells per colony) in 96-well plates, when ECFCs were plated at a seeding density of 1 cell per well. Scale bars, 100 µm. Results represent the average ± s.e.m. of three independent experiments. The y axis represents the percentage of plated single cells. Human lung tissue collection was reviewed and approved by the Institutional Review Board at the University of New Mexico. Specific details about the methods used for phenotypic analysis are available in our earlier report 17 , and information about the antibodies used for cell labeling is provided in supplementary table 1.
CD105 and CD144, but they do not express hematopoietic cell-specific surface antigen CD45 or monocyte/macrophage marker CD14 (see online supplement of ref . 17 for detailed methods; Fig. 5b ). In addition, human lung ECFCs are capable of giving rise to clusters (up to 50 cells) or colonies (50-500 cells or more than 500 cells) in 96-well plates in which ECFCs are plated at a seeding density of 1 cell per well. In three independent trials by the authors, 6.0 ± 1.2 and 7.5 ± 2.9% (mean ± s.d.) of single plated human lung ECFCs formed colonies with 50-500 cells and more than 500 cells, respectively (Fig. 5c) . This characteristic of 'single-cell colony-forming potential' is important in distinguishing ECFCs from mature endothelial cells 13 . The most stringent means to verify the functionality of ECFCs is to assess their ability to contribute to de novo vasculogenesis. To assess this property, ECFCs are loaded on collagen-fibronectin matrices and implanted s.c. in NOD/SCID mice. Cellularized collagen-fibronectin implants are excised 14 d after implantation and examined for vascularization by immunohistochemical staining. RBC-perfused anti-human CD31 + vessels are identified in implants loaded with human lung ECFCs (Fig. 6) .
Rat lung ECFCs isolated by this protocol also demonstrate all the defining characteristics of ECFCs, as shown in Alphonse et al. 17 . Rat ECFCs express endothelial surface markers VCAM-1 and ICAM-2 (refs. 15, 24) . They also express CD34 and c-Kit, which are cell-surface antigens previously identified on endothelial and hematopoietic progenitor cells 15, 25 ( Fig. 7 ; see also supplementary table 2 for antibodies used in this figure) . In addition to binding Ulex europaeus lectin, rat lung ECFCs also bind the lectin from Griffonia simplicifolia, indicating its probable origin from lung microvasculature 26 . 
